These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27741170)

  • 1. Development of an Ex Vivo Organ Culture Technique to Evaluate Probiotic Utilization in IBD.
    Pagnini C; Martorelli M; Lanini C; Delle Fave G
    J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S179-S182. PubMed ID: 27741170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model.
    Tsilingiri K; Barbosa T; Penna G; Caprioli F; Sonzogni A; Viale G; Rescigno M
    Gut; 2012 Jul; 61(7):1007-15. PubMed ID: 22301383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A major advance in ex vivo intestinal organ culture.
    Wildenberg ME; van den Brink GR
    Gut; 2012 Jul; 61(7):961-2. PubMed ID: 22315470
    [No Abstract]   [Full Text] [Related]  

  • 4. Probiotics and their derivatives as treatments for inflammatory bowel disease.
    Prisciandaro L; Geier M; Butler R; Cummins A; Howarth G
    Inflamm Bowel Dis; 2009 Dec; 15(12):1906-14. PubMed ID: 19373788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Lactic Acid Probiotic Bacteria in IBD.
    Vemuri R; Gundamaraju R; Eri R
    Curr Pharm Des; 2017; 23(16):2352-2355. PubMed ID: 28176664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbes, intestinal inflammation and probiotics.
    Khan MW; Kale AA; Bere P; Vajjala S; Gounaris E; Pakanati KC
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):81-94. PubMed ID: 22149584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should probiotics be tested on ex vivo organ culture models?
    Tsilingiri K; Rescigno M
    Gut Microbes; 2012; 3(5):442-8. PubMed ID: 22713266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics: The scientific evidence in the context of inflammatory bowel disease.
    Celiberto LS; Bedani R; Rossi EA; Cavallini DC
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
    Yu CG; Huang Q
    J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, controlled trial evaluating the effect of multi-strain probiotic on the mucosal microbiota in canine idiopathic inflammatory bowel disease.
    White R; Atherly T; Guard B; Rossi G; Wang C; Mosher C; Webb C; Hill S; Ackermann M; Sciabarra P; Allenspach K; Suchodolski J; Jergens AE
    Gut Microbes; 2017 Sep; 8(5):451-466. PubMed ID: 28678609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
    Geier MS; Butler RN; Howarth GS
    Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease.
    Wasilewski A; Zielińska M; Storr M; Fichna J
    Inflamm Bowel Dis; 2015 Jul; 21(7):1674-82. PubMed ID: 25822014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of probiotics: recent advances.
    Ng SC; Hart AL; Kamm MA; Stagg AJ; Knight SC
    Inflamm Bowel Dis; 2009 Feb; 15(2):300-10. PubMed ID: 18626975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease.
    Kanai T; Mikami Y; Hayashi A
    J Gastroenterol; 2015 Sep; 50(9):928-39. PubMed ID: 25940150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
    Gallo A; Passaro G; Gasbarrini A; Landolfi R; Montalto M
    World J Gastroenterol; 2016 Aug; 22(32):7186-202. PubMed ID: 27621567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Probiotics for inflammatory bowel disease].
    Iizuka H; Takaishi H; Hibi T
    Nihon Rinsho; 2005 May; 63(5):776-80. PubMed ID: 15881169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.